Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Kang'enbei Tianshikang Pharmaceutical is a China-based pharmaceutical manufacturer focused primarily on traditional Chinese medicine and other finished-dose drug products. The company is active in drug production, drug wholesale, and the manufacture of traditional Chinese medicine extracts, and markets products in China. Publicly visible evidence indicates that it sells multiple approved commercial products, including gastrointestinal, respiratory, pain, and women's health medicines such as Changyanning granules and other established Chinese medicine products. The business appears to operate mainly as a commercial manufacturing and product company rather than a venture-stage biotech with a disclosed innovative clinical pipeline. It is associated with the Conba healthcare/pharmaceutical group and operates from Yingtan, Jiangxi.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Tianshikang.